Crowley J P, Ree H J, Esparza A
J Clin Immunol. 1982 Oct;2(4):270-5. doi: 10.1007/BF00915066.
A factor inhibitory to PHA-induced lymphocyte blastogenesis was found to be present in the serum of a patient with advanced Hodgkin's disease and nephrotic syndrome. The inhibitory activity for both syngeneic and allogeneic lymphocytes was dependent on the presence of peripheral blood monocytes. The Raji-cell serum assay, as well as immunofluorescence and light and electron microscopy of the renal biopsy, showed no evidence of immune complexes. Nevertheless, a high serum IgE level as well as the finding that ultracentrifugation and heating at 56 degrees C significantly reduced the inhibitory activity (P less than 0.01) suggested the possibility that an immune complex might have mediated the suppressive activity. Treatment of the Hodgkin's disease with combined chemotherapy caused a marked reduction in the monocyte-dependent serum inhibitory activity which in turn coincided with a prompt remission of the nephrotic syndrome and marked regression of disease.
在一名晚期霍奇金病合并肾病综合征患者的血清中,发现了一种抑制PHA诱导淋巴细胞增殖的因子。对同基因和异基因淋巴细胞的抑制活性均依赖于外周血单核细胞的存在。Raji细胞血清检测以及肾活检的免疫荧光、光学和电子显微镜检查均未发现免疫复合物的证据。然而,高血清IgE水平以及超速离心和56℃加热显著降低抑制活性(P<0.01)这一发现提示,免疫复合物可能介导了抑制活性。联合化疗治疗霍奇金病导致单核细胞依赖性血清抑制活性显著降低,这反过来又与肾病综合征迅速缓解和疾病明显消退同时出现。